Europe Interventional
Oncology Market Overview:
Europe Interventional
Oncology Market estimated at $ 522 million
in 2018 and is expected to reach $ 816 million
in 2025, increasing at a compound annual growth rate of 6 % over the 2018-2025 forecast period.
Interventional oncology is a branch of medical science that
deals with minimally invasive medical procedures performed by interventional
radiologists for the diagnosis, treatment and palliation of different types of
cancer. Several image-guided techniques are used in this process such as
computed tomography, fluoroscopy and ultrasound to diagnose and treat the
specific site affected by pain or cancer. The interventional oncology procedure
is performed more frequently with other treatments of cancer such as surgery,
chemotherapy and radiotherapy.
Browse details of 140
number of pages research report developed on Europe Interventional Oncology
Market Research Report @ https://www.researchcosmos.com/reports/europe-interventional-oncology-market/80293991
Europe Interventional
Oncology Market Growth Drivers, Challenges and Opportunities
The growing demand for minimally invasive therapies is the
main driver of the European market growth. These procedures could also be used
to treat patients with other related comorbidities and inoperable patients. The
ability of minimally invasive techniques to treat cancer cells better than
alternative cancer treatments, such as radiotherapy, surgery and routine
chemotherapy, has allowed this technique to gain popularity. In addition,
health professionals and patients are progressively opting for minimally
invasive procedures in the area of interventional oncology because of the
advantages of such techniques, such as shorter hospital stay, minimal risk of
infection, less complications, less pain and faster recovery time compared to
conventional surgeries. These benefits of using minimally invasive procedures
will stimulate the growth of the European interventional oncology market.
Interventional oncology is used to treat primary or
metastatic cancer, such as liver cancer, kidney cancer, lung cancer, prostate
cancer, breast cancer and pancreatic cancer. Most of these procedures are
performed on an outpatient basis or require an overnight stay at the hospital.
Due to its minimally invasive nature, the required recovery time and
hospitalization are minimal. Some of the popular procedures are pain
palliation, intra-arterial therapies, ablative therapies and neoadjuvant
procedures.
Ask Free Sample of
the Report @ https://www.researchcosmos.com/request/europe-interventional-oncology-market/80293991
Geographic Insights
of Europe Interventional Oncology Market:
Europe is expected to represent the second largest share of
the interventional oncology market due to a large population affected by
chronic cancer, such as hepatocellular carcinoma, lung cancer, kidney cancer
and metastatic colorectal cancer in its nations like the UK, Germany, France,
Spain, Italy, and others.
Key market players:
Key players in the European interventional oncology market
include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BTG
plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson & Johnson), Merit Medical
Systems, Inc. and Sirtex Medical Limited, Siemens Healthineers, Eckert &
Ziegler BEBIG, Varian Medical Systems, Inc. and HealthTronics, Inc etc.
For any queries,
inquire more @ https://www.researchcosmos.com/inquire/europe-interventional-oncology-market/80293991
About Us:
Research Cosmos is a provider of standard and customized
Industry research, business intelligence and consulting services across more
than 100 domains in different industries of the world. We host the trending
Industry reports of the world’s top-notch publishing companies, offering
services to a wide range of customers from students to fortune 500 companies
and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
+1 888 709 8757
No comments:
Post a Comment